Polymeric oligonucleotide prodrugs

Details for Australian Patent Application No. 2004230927 (hide)

Owner Enzon Pharmaceuticals, Inc.

Inventors Zhao, Hong; Greenwald, Richard B.

Agent Griffith Hack

Pub. Number AU-B-2004230927

PCT Pub. Number WO2004/092191

Priority 60/462,070 13.04.03 US

Filing date 9 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 30 June 2011

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/70 (2006.01) - Carbohydrates

C07H 19/10 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 19/20 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092191 Priority application(s): WO2004/092191

30 June 2011 Application Accepted

  Published as AU-B-2004230927

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230928-Tie-2 modulators and methods of use

2004230926-CGRP receptor antagonists